Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2018

01-05-2018 | Retinal Disorders

Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients

Authors: Efrat Fleissig, Mor Pavlovksy, Anat Loewenstein, Dinah Zur, Hadas Newman, Shay Keren, Dafna Goldenberg, Efrat Bar-Ilan, Michaella Goldstein

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 5/2018

Login to get access

Abstract

Purpose

To investigate ocular manifestations in patients with vitiligo by multimodal imaging, including optical coherence tomography (OCT), color fundus photography, and fundus autofluorescence (FAF).

Methods

In this prospective, observational clinical study, vitiligo patients underwent ophthalmologic and dermatologic clinical assessment and imaging by spectral-domain OCT, FAF, and color fundus imaging. Ocular echography was performed as indicated. Statistical analysis was performed using paired T test and Pearson correlation.

Results

A total of 61 eyes of 31 vitiligo patients were examined. Ocular findings consisted of choroidal nevi (n = 10, 32%), of which four (40%) were bilateral; two patients (6.5%) had a prominent choroidal pattern, two (6.5%) had hypopigmentary retinal pigment epithelium (RPE) lesions, and one (3.2%) had peripapillary atrophy of the RPE. Choroidal nevi were demonstrated only in eyes of patients with generalized vitiligo and were more common with upper body involvement (p = 0.02) and more prevalent in women (p = 0.02). Hypopigmentary lesions were detected in two patients and demonstrated on OCT as RPE atrophy and as photoreceptor/RPE changes.

Conclusions

In this case series, vitiligo patients had a higher rate of choroidal nevi than previously reported. The hypopigmentary vitiliginous fundus lesions were depicted on OCT as photoreceptor and RPE atrophy. These findings may suggest the advisability of regular ocular monitoring for vitiligo patients.
Literature
2.
3.
go back to reference Birlea SA, Spritz RA, Norris DA (2012) Vitiligo. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (eds) Fitzpatrick’s dermatology in general medicine, 8th edn. New York, pp 792–803 Birlea SA, Spritz RA, Norris DA (2012) Vitiligo. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (eds) Fitzpatrick’s dermatology in general medicine, 8th edn. New York, pp 792–803
4.
go back to reference Cowan CL Jr, Halder RM, Grimes PE, Chakrabarti SG, Kenney JA Jr (1986) Ocular disturbances in vitiligo. J Am Acad Dermatol 15:17–24CrossRefPubMed Cowan CL Jr, Halder RM, Grimes PE, Chakrabarti SG, Kenney JA Jr (1986) Ocular disturbances in vitiligo. J Am Acad Dermatol 15:17–24CrossRefPubMed
5.
6.
go back to reference Karadag R, Esmer O, Karadag AS, Bilgili SG, Cakici O, Demircan YT, Bayramlar H (2016) Evaluation of ocular findings in patients with vitiligo. Int J Dermatol 55:351–355CrossRefPubMed Karadag R, Esmer O, Karadag AS, Bilgili SG, Cakici O, Demircan YT, Bayramlar H (2016) Evaluation of ocular findings in patients with vitiligo. Int J Dermatol 55:351–355CrossRefPubMed
7.
go back to reference Albert DM, Nordlund JJ, Lerner AB (1979) Ocular abnormalities occurring with vitiligo. Ophthalmology 86:1145–1160CrossRefPubMed Albert DM, Nordlund JJ, Lerner AB (1979) Ocular abnormalities occurring with vitiligo. Ophthalmology 86:1145–1160CrossRefPubMed
8.
go back to reference Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A (2006) Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 20:829–833PubMed Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A (2006) Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 20:829–833PubMed
9.
go back to reference Perossini M, Turio E, Perossini T, Cei G, Barachini P (2010) Vitiligo: ocular and electrophysiological findings. Ital Dermatol Venereol 145:141–149 Perossini M, Turio E, Perossini T, Cei G, Barachini P (2010) Vitiligo: ocular and electrophysiological findings. Ital Dermatol Venereol 145:141–149
11.
go back to reference Singh AD, Kalyani P, Topham A (2005) Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 112:1784–1789CrossRefPubMed Singh AD, Kalyani P, Topham A (2005) Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 112:1784–1789CrossRefPubMed
12.
go back to reference Sumich P, Mitchell P, Wang JJ (1998) Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol 116:645–650CrossRefPubMed Sumich P, Mitchell P, Wang JJ (1998) Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol 116:645–650CrossRefPubMed
13.
go back to reference Qiu M, Shields CL (2015) Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey. Ophthalmology 122:2071–2083CrossRefPubMed Qiu M, Shields CL (2015) Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey. Ophthalmology 122:2071–2083CrossRefPubMed
14.
go back to reference Gordon-Shaag A, Barnard S, Millodot M, Gantz L, Chiche G, Vanessa E, Ruth W, Pinchasov R, Gosman Z, Simchi M, Koslowe K, Shneor E (2014) Prevalence of choroidal naevi using scanning laser ophthalmoscope. Ophthalmic Physiol Opt 34:94–101CrossRefPubMed Gordon-Shaag A, Barnard S, Millodot M, Gantz L, Chiche G, Vanessa E, Ruth W, Pinchasov R, Gosman Z, Simchi M, Koslowe K, Shneor E (2014) Prevalence of choroidal naevi using scanning laser ophthalmoscope. Ophthalmic Physiol Opt 34:94–101CrossRefPubMed
15.
go back to reference Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689–696CrossRefPubMed Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689–696CrossRefPubMed
16.
17.
go back to reference Lerner AB, Nordlund JJ (1977) Should vitiligo be induced in patients after resection of primary melanoma? Arch Dermatol 113:421CrossRefPubMed Lerner AB, Nordlund JJ (1977) Should vitiligo be induced in patients after resection of primary melanoma? Arch Dermatol 113:421CrossRefPubMed
18.
go back to reference Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB (1982) Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol 118:34–36CrossRefPubMed Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB (1982) Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol 118:34–36CrossRefPubMed
19.
go back to reference Shields CL, Maktabi AM, Jahnle E, Mashayekhi A, Lally SE, Shields JA (2010) Halo nevus of the choroid in 150 patients: the 2010 Henry van dyke lecture. Arch Ophthalmol 128:859–864CrossRefPubMed Shields CL, Maktabi AM, Jahnle E, Mashayekhi A, Lally SE, Shields JA (2010) Halo nevus of the choroid in 150 patients: the 2010 Henry van dyke lecture. Arch Ophthalmol 128:859–864CrossRefPubMed
20.
go back to reference Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I (2013) Association of halo nevus/I and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol 27:48–52CrossRef Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I (2013) Association of halo nevus/I and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol 27:48–52CrossRef
21.
go back to reference Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77:1–13CrossRefPubMed Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77:1–13CrossRefPubMed
22.
go back to reference Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ, Weetman AP (2011) Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol 20:35–40CrossRefPubMed Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ, Weetman AP (2011) Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol 20:35–40CrossRefPubMed
23.
go back to reference Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 139:798–805CrossRefPubMed Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 139:798–805CrossRefPubMed
24.
go back to reference Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 109:495–500CrossRefPubMedPubMedCentral Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 109:495–500CrossRefPubMedPubMedCentral
25.
go back to reference Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G, Youinou P, Fishman P (1996) Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105:84–88CrossRefPubMedPubMedCentral Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G, Youinou P, Fishman P (1996) Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105:84–88CrossRefPubMedPubMedCentral
26.
go back to reference Nakamura Y, Tanaka R, Asami Y, Teramoto Y, Imamura T, Sato S, Maruyama H, Fujisawa Y, Matsuya T, Fujimoto M, Yamamoto A (2017) Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: a multi-institutional retrospective study. J Dermatol 44:117–122CrossRefPubMed Nakamura Y, Tanaka R, Asami Y, Teramoto Y, Imamura T, Sato S, Maruyama H, Fujisawa Y, Matsuya T, Fujimoto M, Yamamoto A (2017) Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: a multi-institutional retrospective study. J Dermatol 44:117–122CrossRefPubMed
27.
go back to reference Hann SK, Lee HJ (1996) Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671–674CrossRefPubMed Hann SK, Lee HJ (1996) Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671–674CrossRefPubMed
28.
go back to reference Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811–815CrossRefPubMed Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811–815CrossRefPubMed
29.
go back to reference Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148:445–450CrossRefPubMed Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148:445–450CrossRefPubMed
Metadata
Title
Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients
Authors
Efrat Fleissig
Mor Pavlovksy
Anat Loewenstein
Dinah Zur
Hadas Newman
Shay Keren
Dafna Goldenberg
Efrat Bar-Ilan
Michaella Goldstein
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 5/2018
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-3958-0

Other articles of this Issue 5/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2018 Go to the issue